We are delighted to announce our newest themed issue on Covalent Drug Design, which is Guest Edited by Dr. Lyn Jones (Dana-Faber Cancer Institute), Prof. Keriann Backus (UCLA), and Prof. Zhengying Pan (Peking University).
This issue on covalent drug design will include areas such as covalent fragment-based drug discovery, reversible covalent warhead design, structure-based drug design and covalent docking and covalent chemical probes, natural products and degraders. For more information about the scope of this issue, or if you would like to contribute an article to this collection, please contact the Editorial Office at medchem-rsc@rsc.org.
Submissions are open from now until 3 June 2021
New research in RSC Medicinal Chemistry is published as Research Articles. This article type encompasses both Communication and Full Paper styles with no strict page limit.
All manuscripts will be subject to the journal’s usual peer review process. Accepted manuscripts will be highlighted together in a dedicated virtual issue alongside an editorial by our guest editors, regardless of submission date, and there will be no delay in the publication of all accepted manuscripts into regular issues of RSC Medicinal Chemistry.
